Results 1 to 10 of about 145,187 (366)

Statins in Non-alcoholic Steatohepatitis [PDF]

Frontiers in Cardiovascular Medicine, 2021
Non-alcoholic fatty liver disease (NAFLD) is the primary cause of chronic liver disease. The range is extensive, including hepatocellular carcinoma, cirrhosis, fibrosis, fatty liver, and non-alcoholic steatohepatitis (NASH).
Jose D. Torres-Peña, Jose D. Torres-Peña, Laura Martín-Piedra, Laura Martín-Piedra, Francisco Fuentes-Jiménez, Francisco Fuentes-Jiménez   +5 more
doaj   +7 more sources

Fructose and Non-Alcoholic Steatohepatitis [PDF]

Frontiers in Pharmacology, 2021
Background: The excessive consumption of free sugars is mainly responsible for the high prevalence of obesity and metabolic syndrome in industrialized countries.
Elke Roeb, Ralf Weiskirchen
doaj   +5 more sources

Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mice [PDF]

Scientific Reports, 2017
While gap junctions mediate intercellular communication and support liver homeostasis, connexin hemichannels are preferentially opened by pathological stimuli, including inflammation and oxidative stress.
Joost Willebrords, Bruno Cogliati, Isabel Veloso Alves Pereira, Tereza Cristina da Silva, Sara Crespo Yanguas, Michaël Maes, Veronica Mollica Govoni, Andressa Lima, Daniele Aparecida Felisbino, Elke Decrock, Marina Sayuri Nogueira, Inar Alves de Castro, Isabelle Leclercq, Luc Leybaert, Robim Marcelino Rodrigues, Mathieu Vinken   +15 more
doaj   +3 more sources

Non-alcoholic steatohepatitis [PDF]

The Lancet, 1999
OFW James, CP Day
  +8 more sources

Rapid development of non-alcoholic steatohepatitis in Psammomys obesus (Israeli sand rat). [PDF]

PLoS ONE, 2014
BACKGROUND AND AIMS: A major impediment to establishing new treatments for non-alcoholic steatohepatitis is the lack of suitable animal models that accurately mimic the biochemical and metabolic characteristics of the disease.
Briana Spolding, Timothy Connor, Carrie Wittmer, Lelia L F Abreu, Antony Kaspi, Mark Ziemann, Gunveen Kaur, Adrian Cooper, Shona Morrison, Scott Lee, Andrew Sinclair, Yann Gibert, James L Trevaskis, Jonathon D Roth, Assam El-Osta, Richard Standish, Ken Walder   +16 more
doaj   +10 more sources

Non-alcoholic Steatohepatitis: An Overview

Journal of the Formosan Medical Association, 2009
Non-alcoholic fatty liver disease (NAFLD) includes a broad spectrum of fat-induced liver injury, ranging from mild steatosis to cirrhosis and liver failure.
Allison Shifflet, George Y. Wu
doaj   +3 more sources

Endocannabinoids and non-alcoholic steatohepatitis

The Saudi Journal of Gastroenterology, 2006
Non alcoholic steatohepatitis (NASH) has gained a lot of attention recently due to the increased prevalence of diabetes, obesity, and hyperlipedemia. The endogenous compounds, endocannabinoids (ECBs), bind to the same receptors as tetrahydrocannabinol ...
Helmy Ahmed
doaj   +3 more sources

Machine learning model for non-alcoholic steatohepatitis diagnosis based on ultrasound radiomics [PDF]

BMC Medical Imaging
Background Non-Alcoholic Steatohepatitis (NASH) is a crucial stage in the progression of Non-Alcoholic Fatty Liver Disease(NAFLD). The purpose of this study is to explore the clinical value of ultrasound features and radiological analysis in predicting ...
Fei Xia, Wei Wei, Junli Wang, Yayang Duan, Kun Wang, Chaoxue Zhang   +5 more
doaj   +2 more sources

Rezdiffra™ (resmetirom): a THR-β agonist for non-alcoholic steatohepatitis. [PDF]

Trends Pharmacol Sci
Brisnovali NF, Haney C, Goedeke L.
europepmc   +3 more sources

Recurrent and de novo non-alcoholic steatohepatitis following orthotopic liver transplantation [PDF]

Arquivos de Gastroenterologia, 2001
Background — Non-alcoholic steatohepatitis was coined in 1980 to describe pathological and clinical features of non-alcoholic disease associated with pathological features, commonly seen in alcoholic-liver disease itself.
Raquel F. Liermann GARCIA, Eugenia MORALES, Christian Evangelista GARCIA, Sushma SAKSENA, Stefan G. HÜBSCHER, Elwin ELIAS   +5 more
doaj   +1 more source